RTS,S/AS01E malaria vaccine induces IgA responses against CSP and vaccine-unrelated antigens in African children in the phase 3 trial.
Suau R, Vidal M, Aguilar R, Ruiz-Olalla G, Vázquez-Santiago M, Jairoce C, Nhabomba AJ, Gyan B, Dosoo D, Asante KP, Owusu-Agyei S, Campo JJ, Izquierdo L, Cavanagh D, Coppel RL, Chauhan V, Angov E, Dutta S, Gaur D, Beeson JG, Moncunill G, Dobaño C.
Suau R, et al.
Vaccine. 2021 Jan 22;39(4):687-698. doi: 10.1016/j.vaccine.2020.12.038. Epub 2020 Dec 25.
Vaccine. 2021.
PMID: 33358704
Clinical Trial.